Evidence map›Paper›PMID 29340929›Full record

ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2018

S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life.

Jin Gao, Catherine M Cahill, Xudong Huang, Joshua L Roffman, Stefania Lamon-Fava, Maurizio Fava, David Mischoulon, Jack T Rogers

Open access · bronzeAbstract readReview
In one paragraph

Review in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 127 citations in OpenAlex.

  1. Behavioral sciences (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Vitamin D and Vitamin BDiseases (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Folate intake,The British journal of nutrition · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jin GaoDepartment of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Catherine M CahillNeurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Xudong HuangNeurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Joshua L RoffmanDepartment of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Stefania Lamon-FavaJean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA.
Maurizio FavaDepartment of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
David MischoulonDepartment of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Jack T RogersNeurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. jack.rogers@mgh.harvard.edu.
Massachusetts General Hospital · USHarvard University · USJean Mayer Human Nutrition Research Center on Aging · USQilu Hospital of Shandong University · CN

Funding

Neurobiological Underpinnings of Placebo Response in DepressionR01MH102279 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI CUSIN, CRISTINA, FAVA, MAURIZIO · 2015 to 2019
$3.9M
Nanoneurotoxicity of Metal Oxide Nanomaterials and NeurodegenerationR01AG056614 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HUANG, XUDONG · 2017 to 2020
$1.5M
Post Transcriptional Control of hemorrhagic iron damage.R21NS077079 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROGERS, JACK T · 2012 to 2013
$458k
RNA Targeted Screens of the Prion 5'UTRR21NS064853 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROGERS, JACK T · 2008 to 2010
$270k
MLSN Screen of the PD Alpha Synuclein 5'UTRR21NS059434 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROGERS, JACK T · 2007 to 2008
$263k
NIA NIH HHS R01 AG056614NIH HHS NS077079NIH HHS R01MH102279NIMH NIH HHS R01 MH102279NINDS NIH HHS R21 NS077079
6 · The paper itself

Abstract

S-Adenosyl methionine (SAMe), as a major methyl donor, exerts its influence on central nervous system function through cellular transmethylation pathways, including the methylation of DNA, histones, protein phosphatase 2A, and several catecholamine moieties. Based on available evidence, this review focuses on the lifelong range of severe neuropsychiatric and neurodegenerative diseases and their associated neuropathologies, which have been linked to the deficiency/load of SAMe production or/and the disturbance in transmethylation pathways. Also included in this review are the present-day applications of SAMe in the treatment in these diseases in each age group.

Indexed as

AnimalsDNA MethylationEpigenesis, GeneticHumansMental DisordersMethylationNeurodegenerative DiseasesS-AdenosylmethionineSignal TransductionS-AdenosylmethionineNeurodegenerative diseasePathwayPsychiatric diseaseS-Adenosyl-methionineTransmethylation

Identifiers

PMID29340929
PMCPMC5794704
OpenAlexW2784314859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.